Naoki Kawahara

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

Trials

Microorganisms

Diagnostics (Basel, Switzerland)

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Naoki Kawahara, Shoichiro Yamanaka, Kyohei Nishikawa, Motoki Matsuoka, Tomoka Maehana, Ryuji Kawaguchi, Naoki Ozu, Tomomi Fujii, Aya Sugimoto, Akihiko Yoshizawa, Fuminori Kimura
Endogenous Microbacteria Can Contribute to Ovarian Carcinogenesis by Reducing Iron Concentration in Cysts: A Pilot Study. Microorganisms 12 (3) (2024)
Naoki Kawahara, Shoichiro Yamanaka, Kyohei Nishikawa, Motoki Matsuoka, Tomoka Maehana, Ryuji Kawaguchi, Naoki Ozu, Tomomi Fujii, Aya Sugimoto, Akihiko Yoshizawa, Fuminori Kimura
Endogenous Microbacteria Can Contribute to Ovarian Carcinogenesis by Reducing Iron Concentration in Cysts: A Pilot Study. Microorganisms 12 (3) (2024)
Naoki Kawahara, Ryuji Kawaguchi, Konosuke Yamamoto, Kyohei Nishikawa, Motoki Matsuoka, Tomoka Maehana, Yosuke Fukui, Shoichiro Yamanaka, Sumire Sugimoto, Kana Iwai, Yuki Yamada, Hiroyuki Kurakami, Takumi Hirata, Ryuzo Takashima, Shota Suzuki, Kiyoshi Asada, Masato Kasahara, Fuminori Kimura
The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial. Trials 25 (1) (2024)
Naoki Kawahara, Hiroshi Kobayashi, Tomoka Maehana, Kana Iwai, Yuki Yamada, Ryuji Kawaguchi, Junko Takahama, Nagaaki Marugami, Hirotaka Nishi, Yosuke Sakai, Hirokuni Takano, Toshiyuki Seki, Kota Yokosu, Yukihiro Hirata, Koyo Yoshida, Takafumi Ujihira, Fuminori Kimura
MR Relaxometry for Discriminating Malignant Ovarian Cystic Tumors: A Prospective Multicenter Cohort Study. Diagnostics (Basel, Switzerland) 14 (11) (2024)
Naoki Kawahara, Ryuji Kawaguchi, Konosuke Yamamoto, Kyohei Nishikawa, Motoki Matsuoka, Tomoka Maehana, Yosuke Fukui, Shoichiro Yamanaka, Sumire Sugimoto, Kana Iwai, Yuki Yamada, Hiroyuki Kurakami, Takumi Hirata, Ryuzo Takashima, Shota Suzuki, Kiyoshi Asada, Masato Kasahara, Fuminori Kimura
The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial. Trials 25 (1) (2024)
Naoki Kawahara, Ryuji Kawaguchi, Konosuke Yamamoto, Kyohei Nishikawa, Motoki Matsuoka, Tomoka Maehana, Yosuke Fukui, Shoichiro Yamanaka, Sumire Sugimoto, Kana Iwai, Yuki Yamada, Hiroyuki Kurakami, Takumi Hirata, Ryuzo Takashima, Shota Suzuki, Kiyoshi Asada, Masato Kasahara, Fuminori Kimura
The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial. Trials 25 (1) (2024)
Naoki Kawahara, Shoichiro Yamanaka, Kyohei Nishikawa, Motoki Matsuoka, Tomoka Maehana, Ryuji Kawaguchi, Naoki Ozu, Tomomi Fujii, Aya Sugimoto, Akihiko Yoshizawa, Fuminori Kimura
Endogenous Microbacteria Can Contribute to Ovarian Carcinogenesis by Reducing Iron Concentration in Cysts: A Pilot Study. Microorganisms 12 (3) (2024)
Naoki Kawahara, Ryuji Kawaguchi, Konosuke Yamamoto, Kyohei Nishikawa, Motoki Matsuoka, Tomoka Maehana, Yosuke Fukui, Shoichiro Yamanaka, Sumire Sugimoto, Kana Iwai, Yuki Yamada, Hiroyuki Kurakami, Takumi Hirata, Ryuzo Takashima, Shota Suzuki, Kiyoshi Asada, Masato Kasahara, Fuminori Kimura
The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial. Trials 25 (1) (2024)
Naoki Kawahara, Hiroshi Kobayashi, Tomoka Maehana, Kana Iwai, Yuki Yamada, Ryuji Kawaguchi, Junko Takahama, Nagaaki Marugami, Hirotaka Nishi, Yosuke Sakai, Hirokuni Takano, Toshiyuki Seki, Kota Yokosu, Yukihiro Hirata, Koyo Yoshida, Takafumi Ujihira, Fuminori Kimura
MR Relaxometry for Discriminating Malignant Ovarian Cystic Tumors: A Prospective Multicenter Cohort Study. Diagnostics (Basel, Switzerland) 14 (11) (2024)
Naoki Kawahara, Shoichiro Yamanaka, Sumire Sugimoto, Junya Kamibayashi, Kyohei Nishikawa, Ryuji Kawaguchi, Fuminori Kimura
The Prognosis Predictive Score around Neo Adjuvant Chemotherapy (PPSN) Improves Diagnostic Efficacy in Predicting the Prognosis of Epithelial Ovarian Cancer Patients. Cancers 15 (20) (2023)
Yuki Yamada, Ryuji Kawaguchi, Kana Iwai, Keita Waki, Naoki Kawahara, Fuminori Kimura
Successful vaginoscopic excision of the vaginal septum in a virgin girl of obstructed hemivagina and ipsilateral renal anomaly: Case report and review of literature. The journal of obstetrics and gynaecology research (2022)
Shoichiro Yamanaka, Naoki Kawahara, Ryuji Kawaguchi, Keita Waki, Tomoka Maehana, Yosuke Fukui, Ryuta Miyake, Yuki Yamada, Hiroshi Kobayashi, Fuminori Kimura
The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy. Diagnostics (Basel, Switzerland) 12 (5) (2022)
Naoki Kawahara, Ryuji Kawaguchi, Tomoka Maehana, Shoichiro Yamanaka, Yuki Yamada, Hiroshi Kobayashi, Fuminori Kimura
The Endometriotic Neoplasm Algorithm for Risk Assessment (e-NARA) Index Sheds Light on the Discrimination of Endometriosis-Associated Ovarian Cancer from Ovarian Endometrioma. Biomedicines 10 (11) (2022)
Naoki Kawahara, Yuki Yamada, Hiroshi Kobayashi
CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma. International journal of molecular sciences 22 (11) (2021)
Naoki Kawahara, Ryuta Miyake, Shoichiro Yamanaka, Hiroshi Kobayashi
A Novel Predictive Tool for Discriminating Endometriosis Associated Ovarian Cancer from Ovarian Endometrioma: The R2 Predictive Index. Cancers 13 (15) (2021)
Emiko Niiro, Naoki Kawahara, Yuki Yamada, Chiharu Yoshimoto, Keiji Shimada, Tamotsu Sudo, Hiroshi Kobayashi
Immunohistochemical expression of CD44v9 and 8-OHdG in ovarian endometrioma and the benign endometriotic lesions adjacent to clear cell carcinoma. The journal of obstetrics and gynaecology research 45 (11) (2019)

Naoki Kawahara.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Naoki Kawahara